Deciphera Pharmaceuticals’ Post

Today Deciphera, a member of ONO Pharma, announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for vimseltinib for priority review. Read more: https://bit.ly/3WZ4PgQ

Deciphera employees recognized #SarcomaAwarenessMonth and #GISTAwarenessDay this year by participating in group activities, including a #sarcoma research fundraising walk, to raise awareness and education for these complex cancers. We’re proud of our team for showing their continued commitment to our mission to discover, develop, and deliver important new medicines to patients for the treatment of cancer. Learn more about the Deciphera difference: https://lnkd.in/eVxsxaq7 #GIST #CureSarcoma

Today Deciphera, a member of ONO Pharma, announced that the marketing authorization application (MAA) for vimseltinib was accepted for review by the European Medicines Agency (EMA.) Read more: https://bit.ly/3W9OHYb #ONOPHARMA

Today is #GISTAwarenessDay, a chance for patients, caregivers, doctors and others in the #GIST community to raise awareness for people living with this rare sarcoma. Each one of us at Deciphera is united in our mission to discover, develop and deliver medicines to patients for the treatment of cancers like GIST. Learn more: https://bit.ly/3Q1W8i7

July is #SarcomaAwarenessMonth, a time for the sarcoma community to come together to advocate and raise awareness for those living with these rare and complex cancers. Please join us in raising awareness and wearing your yellow ribbon. #CureSarcoma

Each year the LGBTQ+ community and allies come together to amplify LGBTQ+ voices, experiences, and advocate for equality. This year, Deciphera’s Diversity, Equity and Inclusion employee resource group co-hosted a gathering with neighboring companies to celebrate #PRIDE together.   Our Deciphera community invests in fostering an inclusive environment where everyone can bring their full selves to work, and by doing so, ensure that we are delivering on our mission for patients. Learn more about our culture: https://bit.ly/3W13Qft

As of today, Deciphera is officially a member of ONO Pharma. Together, we remain focused on discovering, developing and delivering important new medicines to patients for the treatment of cancer. Learn more: https://lnkd.in/gbFyqhNg